毕得医药(688073.SH)部分股东拟合计减持不超1%股份

Core Viewpoint - Bid Pharma (688073.SH) announced a share reduction plan by certain shareholders due to their liquidity needs, intending to sell up to 1% of the company's total share capital within three months from the disclosure date [1] Group 1 - Shareholders involved in the reduction plan include Li Yijing, Chen Jun, Li Li, Du Juan, Li Aifei, Geng Yong, and Jiang Yamei [1] - The reduction will be executed through centralized bidding, starting three trading days after the announcement [1] - The total number of shares to be reduced will not exceed 1% of the company's total share capital [1]